Jefferies Raises Price Target on Quest Diagnostics (DGX) to $86 Following 2Q Earnings Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Quest Diagnostics Reports Second Quarter 2016 Financial Results
July 21, 2016 6:45 AM EDTMADISON, N.J., July 21, 2016 /PRNewswire/ --Â Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that for the second quarter ended June 30, 2016, reported net income was $195 million, or $1.37 per diluted share, compared to $118 million, or $0.81 per diluted share, in 2015.
Adjusted net income was $178 million, compared to $170 million in 2015. Adjusted diluted EPS excluding amortization was $1.34 in the quarter, compared to $1.25 in 2015. In the second quarter of 2016, reported net income was favorably... More
